Possible target identified for treatment for 50% of cancers

07-07-2025

Cancer cells often acquire exploitable vulnerabilities resulting from their genetic alterations. Identifying these susceptibilities is crucial as they can serve as new targets for precision medicines. In a study published in Nature Genetics, Daniel Peeper’s research group at the Netherlands Cancer Institute describes one of these genes, which plays a role in half of all cancers.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.